Navigation Links
PCAN Calls On Federal Government to Reconsider Preliminary Approval of Texas' Medicaid Waiver Request
Date:9/19/2011

DALLAS, Sept. 19, 2011 /PRNewswire/ -- Pharmacy Choice and Access Now (PCAN) - a coalition of consumers, local businesses and pharmacists across the nation and Texas committed to preserving quality and affordable health care - today called on the Centers for Medicare and Medicaid Services (CMS) to reconsider their preliminary approval of Texas' waiver implementing a new Medicaid managed care plan switching pharmacy, among other health care services, to a managed-care model.

PCAN believes the Centers for Medicare and Medicaid Services (CMS) should reject the State of Texas' proposed Section 1115 waiver now pending before the agency, citing a precipitous decline in reimbursement rates that will force pharmacies out of business, as well as threaten patient services and access to care.

"The State's proposed implementation of managed care pharmacy services will devastate pharmacies in the state, kill jobs and hurt the quality of patient care for the most vulnerable among us.  It must be stopped in its tracks," said Tammy Gray, RPh, owner of a pharmacy in Buda and spokesperson for the Pharmacy Choice and Access Now (PCAN) coalition in Texas.

According to the group, the proposed implementation of the managed care model will drastically reduce reimbursement rates for local pharmacies that fill prescriptions and could force some out of business altogether and even more out of the Texas Medicaid program.  Currently, pharmacies receive reimbursement for Medicaid prescriptions through the Vendor Drug Program regulated by the state and open to all pharmacies.  Under the new plan, they will be subject to rates set by pharmacy benefits managers (PBMs) and managed care organizations, for-profit firms that will administer the managed care pharmacy program.

Independent pharmacies across Texas have already begun receiving contracts from at least one PBM that represents an 80 percent reduction in reimbursement rates per prescription dispensed or Medicaid patients.  Such drastic cuts are unsustainable for many pharmacies, particularly those in underserved rural and urban areas where prescription volume is heavily geared toward Medicaid recipients.

According to a study conducted for PCAN by The Perryman Group, proposed reimbursement cuts and the move to managed care would lead to the closure of hundreds of pharmacies, the loss of thousands of jobs and the elimination of access to pharmacies in many areas, both for the general population and for those receiving Medicaid.  The Perryman Group estimated nearly 43,000 job losses, 770 pharmacy closures and a $3.1 billion loss to the economy from the move to managed care for pharmacy.

PCAN further stressed that the managed care model is inappropriate for many segments of the Medicaid population, including the blind and disabled, who rely heavily on special services and counseling provided by pharmacists in addition to prescriptions.

"All Texans should be concerned about what's at stake here: quality health care, access to their local pharmacy and jobs in their community," concluded Gray.

Gray urged local pharmacists and concerned citizens to sign the Texas Pharmacy Protection Petition at www.rxchoiceandaccess.com.

About PCAN

Pharmacy Choice and Access Now (PCAN) is a coalition of consumers, local business and pharmacists across the nation committed to preserving quality and affordable health care and pharmacy services for patients.  We are committed to providing the most cost-effective solutions in the areas of health care and pharmacy services to enable states around the country to help solve their budget woes, while maintaining quality care for children, families and other Medicaid-served populations.

For more information on Pharmacy Choice and Access Now (PCAN), visit www.rxchoiceandaccess.com.


'/>"/>
SOURCE Pharmacy Choice and Access Now (PCAN)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mainor Eglet Attorney, Robert Eglet, Calls Teva Pharmaceuticals Vice President Craig Lea to the Stand in Hepatitis C Trial
2. Independent Expert Panel Calls for Information on Fragrance Ingredients Under Review
3. AVAC Says Results of New PrEP Trials Provide Clear Evidence that Antiretroviral Drugs for Prevention Can Help End the AIDS Epidemic; Calls for Quick Action to Move Landmark HIV Prevention Results Toward Lifesaving Programs
4. Lilly CEO Calls for Improved Dialogue in Germany Between Industry and the Government and Health Care System
5. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
6. Ortho-McNeil Neurologics Voluntarily Recalls Two Lots of TOPAMAX®
7. Lilly CEO Calls for Biopharmaceutical Industry Changes and Policies That Encourage Medical Innovation
8. Cherokee Inspired Comfort Award Calls for Healthcare Professional Nominations
9. B. Braun Voluntarily Recalls Seven Lots of Heparin Manufactured in 2008 Due to Supplier-Initiated Recall of Heparin Active Pharmaceutical Ingredient (API)
10. International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women
11. American Society of Tropical Medicine and Hygiene (ASTMH) Calls for Stronger FDA Science Investment to Better Fight Diseases of Poverty Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Zynex (OTCQB: ZYXI), an innovative ... of non-invasive medical devices for pain management, stroke rehabilitation, ... will host the Company,s 2016 full-year investor webcast on Monday, ... The Company expects to file its 2016 ... ...
(Date:3/29/2017)... , March 29, 2017 According to a new ... Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, ... 2021" published by MarketsandMarkets, the market is expected to reach USD 1,215.4 ... of 6.5% from 2016 to 2021. Continue ... ...
(Date:3/29/2017)... WASHINGTON , March 29, 2017  The Pharmaceutical ... regarding a new PhRMA report on patient out-of-pocket spending: ... for Medicare and Medicaid Services (CMS), the average amount ... be 13% of drug spending in 2016, down from ... is a pricing problem, not a coverage problem. Health ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... 2017 , ... In the United States alone, up to 36% of primary ... of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known ... effective treatment options, the San Diego Gamma Knife Center offers a precision-medicine ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered ... feedback from high school and college students who have participated in the program every ... and YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to ...
(Date:3/29/2017)... Burnaby, BC (PRWEB) , ... March 29, 2017 ... ... smile makeover services with or without a referral to new patients from Burnaby, ... implants or other full mouth reconstruction services, can see the esteemed team ...
(Date:3/29/2017)... ... March 29, 2017 , ... How ... other outpatient facilities, and who are the most active developers? , In ... and Healthcare Real Estate Insights (HREI) found that outpatient medical real estate development ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
Breaking Medicine News(10 mins):